Low-dose Rituximab Monotherapy or in Combination with Tacrolimus Is Effective in Primary Membranous Nephropathy

被引：3
|
作者：
Pathak, Vivek [1 ]
Venkatesan, Madhav [1 ]
Regunathan-Shenk, Renu [1 ,2 ]
机构：
[1] Kovai Med Ctr & Hosp, Nephrol, Coimbatore 641014, Tamil Nadu, India
[2] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA
来源：
KIDNEY360 | 2021年 / 2卷 / 02期
关键词：
clinical nephrology; cyclosporine; membranous glomerulonephritis; remission induction; rituximab; tacrolimus;
D O I：
10.34067/KID.0004672020
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：336 / 338
页数：3
相关论文
共 50 条
  • [21] Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy
    Xu, Mingyue
    Wang, Yifeng
    Wu, Meihe
    Chen, Ruiying
    Zhao, Wenqian
    Li, Mingxin
    Hao, Chuan-Ming
    Xie, Qionghong
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, : 978 - 986
  • [22] Efficacy and safety of tacrolimus monotherapy versus cyclophosphamide-corticosteroid combination therapy for idiopathic membranous nephropathy A meta-analysis
    Gong, Lifeng
    Xu, Min
    Xu, Wei
    Tang, Weigang
    Lu, Jingkui
    Jiang, Wei
    Xie, Fengyan
    Ding, Liping
    Qian, Xiaoli
    MEDICINE, 2021, 100 (28) : E26628
  • [23] Efficacy of mizoribine followed by low-dose prednisone in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria
    Matsumoto, Yoshihiro
    Shimada, Yasushi
    Nojima, Youichi
    Moriki, Toshiaki
    RENAL FAILURE, 2013, 35 (07) : 936 - 941
  • [24] Comparison of Obinutuzumab and Rituximab for Treating Primary Membranous Nephropathy
    Hu, Xiaofan
    Zhang, Muyin
    Xu, Jing
    Gao, Chenni
    Yu, Xialian
    Li, Xiao
    Ren, Hong
    Wang, Weiming
    Xie, Jingyuan
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (12): : 1594 - 1602
  • [25] Efficacy and Safety of Low-Dose Chlorambucil in Nephrotic Patients with Idiopathic Membranous Nephropathy
    Idasiak-Piechocka, Ilona
    Oko, Andrzej
    Lochynska-Bielecka, Katarzyna
    Skrobanska, Beata
    KIDNEY & BLOOD PRESSURE RESEARCH, 2009, 32 (04) : 263 - 267
  • [26] Tacrolimus in resistant primary membranous nephropathy - a report of 3 cases
    Szeto, CC
    Leung, CB
    Lai, FMM
    Li, PKT
    CLINICAL NEPHROLOGY, 2003, 59 (04) : 293 - 296
  • [27] Low-dose rituximab in adult patients with primary immune thrombocytopenia
    Zaja, Francesco
    Vianelli, Nicola
    Volpetti, Stefano
    Battista, Marta Lisa
    Defina, Marzia
    Palmieri, Salvatore
    Bocchia, Monica
    Medeot, Marta
    De Luca, Stefano
    Ferrara, Felicetto
    Isola, Miriam
    Baccarani, Michele
    Fanin, Renato
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (04) : 329 - 334
  • [28] Optimization of rituximab therapy in primary membranous nephropathy with artificial intelligence
    Destere, A.
    Teyssiere, M.
    Merino, D.
    Cremoni, M.
    Benito, S.
    Gerard, A.
    Drici, M. D.
    Seitz-Polski, B.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 74 - 75
  • [29] The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy
    Liang, Qian
    Li, Heng
    Xie, Xishao
    Qu, Fangzhi
    Li, Xiayu
    Chen, Jianghua
    RENAL FAILURE, 2017, 39 (01) : 512 - 518
  • [30] Low-dose cyclosporine in treatment of membranous nephropathy with nephrotic syndrome: effectiveness and renal safety
    Yu, Xiaojuan
    Ruan, Lin
    Qu, Zhen
    Cui, Zhao
    Zhang, Yimiao
    Wang, Xin
    Meng, Liqiang
    Liu, Xiaojing
    Wang, Fang
    Zhang, Ying
    Liu, Gang
    Yang, Li
    RENAL FAILURE, 2017, 39 (01) : 688 - 697
12345